Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
about
Interaction between the N-terminus of human topoisomerase I and SV40 large T antigenInhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer TherapyPreclinical Murine Models for Lung Cancer: Clinical Trial ApplicationsDrugging topoisomerases: lessons and challengesThe quest for modernisation of traditional Chinese medicineA unique carrier for delivery of therapeutic compounds beyond the blood-brain barrierDrug discovery prospect from untapped species: indications from approved natural product drugsDNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial InhibitionLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Promoting human health through forests: overview and major challengesA phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion.A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.A High Throughput Assay for Discovery of Bacterial β-Glucuronidase Inhibitors.Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugsAntiviral lead compounds from marine sponges.How Taxol/paclitaxel kills cancer cells.Anticancer Alkaloids from Trees: Development into Drugs.Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.Anti-breast Cancer Agents Derived from Plants.The proliferation rate paradox in antimitotic chemotherapy.Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirusNab-paclitaxel-associated photosensitivity: report in a woman with non-small cell lung cancer and review of taxane-related photodermatoses.Dual Inhibitors Against Topoisomerases and Histone DeacetylasesThe role of oncogenes in drug resistance.Common variants of Drosophila melanogaster Cyp6d2 cause camptothecin sensitivity and synergize with loss of Brca2.The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.Novel therapeutic strategies for metastatic prostate cancer in the post-docetaxel settingUnderstanding resistance to combination chemotherapy.Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.Ethnomedical properties of taxus wallichiana zucc. (Himalayan yew).Bioactive Secondary Metabolites Produced by the Fungal Endophytes of Conifers.Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecinSmall-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs.Low Doses of Camptothecin Induced Hormetic and Neuroprotective Effects in PC12 Cells.Topoisomerases as anticancer targets.Heteronemin, a Marine Sesterterpenoid-Type Metabolite, Induces Apoptosis in Prostate LNcap Cells via Oxidative and ER Stress Combined with the Inhibition of Topoisomerase II and Hsp90.
P2860
Q24547088-220B2EB3-422A-4793-A82E-6C9D8E6B2EADQ26796576-DCD81EF7-04F5-4255-B0BF-EF646B40E60EQ26863474-FAFF99DA-2980-412F-A418-1AA070DAE5BCQ27000099-98A0EA54-E3A3-4B3A-8ADF-A81BAB53958CQ28292682-EA5F3B61-F61A-4A33-8FBB-3B6B69D1951EQ28472987-F36E26F0-FDCA-49C5-9C7F-EC84130785C9Q28481257-C8290584-F7A0-465F-BE65-CEA4D14C3C0EQ29400901-46691D77-0A97-4DC8-BA47-1EC405588C9BQ30366990-3949AE60-8AE1-43AB-BC33-71C423B56688Q33476910-070788C9-7F3D-465C-A106-29AF1D1FD71FQ33504409-771AE786-376E-4F4B-9806-CE0C7454E779Q33812633-CFF1D7F2-721B-4E77-913A-01ACADB48C83Q33923975-7DA30251-0C70-49C1-99DE-0C154A53D20AQ33936160-37FC18A5-C05B-449A-9A80-DFF4E8020C37Q34152399-D101D999-749E-4A27-95A8-8CD149894D95Q34166802-D76B8B96-F867-4B31-A76B-E75EB3A7154BQ34549113-819B67EF-C564-45E9-89F5-DADCC04DA306Q35047219-1EB7FDCE-D7B3-4EDA-B655-69333694A336Q35083223-F2A0A3C4-EA50-4F81-B09B-3E05BBCF47B5Q35642841-7151FC68-10B8-4047-881F-3084A33A11BBQ35689364-6B05F42D-A9C9-445A-A2FC-FB4AAAA91697Q35717645-29CC8301-F57C-4BFF-9E97-F25160D166BFQ35821010-19220DCF-CB4C-4A01-9597-B6F5EBD93FE2Q36254816-F68D11C0-7534-43DA-A6D3-F26A22C51946Q36512681-D442B11C-8120-4CEB-AF29-B16B3643AE1FQ36839637-88995DB5-4C5F-47C3-B2B1-92FB1D061625Q37952048-B6308A45-5DC5-4BCB-9AB4-DDD380E44057Q38060916-E6CD1E89-BC8B-49DD-8037-0B53868764FCQ38097867-50CA7250-D86C-40DD-BDC7-2A49A9298AE7Q38243810-25311197-2C65-455F-9DB0-09CE46315A36Q38669681-6FD6C790-7C21-474F-AC7F-FF4D19976DB3Q40359146-949116AC-17ED-4CBB-8F1E-D9BDA663FCC8Q42116442-68EF8CB6-C44F-4617-8C2C-E4640A6DADBFQ42260343-2A254DF4-1972-4145-A361-97A4AEF4ECF7Q49832269-F3C208D9-7BA1-4169-BA11-2D73F31D8E17Q55515481-5F82EAA0-7492-4344-B64F-1AD4560DCDD6
P2860
Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@ast
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@en
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@nl
type
label
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@ast
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@en
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@nl
prefLabel
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@ast
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@en
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@nl
P1433
P1476
Camptothecin and taxol: discov ...... . Cain Memorial Award Lecture.
@en
P304
P407
P577
1995-02-01T00:00:00Z